It’s a virtuous circle: New approval processes put in place by the European Medicines Agency are de-risking drug development, promoting investment in early-stage biotech and meeting unmet medical needs, says Paul Morton

The EU must take action to translate expertise in key underpinning technologies such as biotechnology, photonics and nanotechnology into industry-powered growth, says EU Commissioner Antonio Tajani

The Third Annual Worldview Bio-Innovation Scorecard report, published by Scientific American, points to progress in Europe

With a strong pipeline of drugs in development, a good flow of venture capital investment and seven IPOs, 2010 was an “exceptional” year, says France Biotech

Europe’s biggest-ever private financing round by a biotech doesn’t mean the capital drought is over, says Martin Edwards of Novo Ventures.

Three life sciences and healthcare networking organisations in the UK have made an agreement with MassBio to promote the biotechnology industry in both regions.